130 related articles for article (PubMed ID: 38342359)
1. Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain.
Antunes FTT; Huang S; Chen L; Zamponi GW
Eur J Pharmacol; 2024 Mar; 967():176416. PubMed ID: 38342359
[TBL] [Abstract][Full Text] [Related]
2. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
3. A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.
Garcia-Caballero A; Gadotti VM; Chen L; Zamponi GW
Mol Pain; 2016; 12():. PubMed ID: 27130589
[TBL] [Abstract][Full Text] [Related]
4. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.
Berger ND; Gadotti VM; Petrov RR; Chapman K; Diaz P; Zamponi GW
Mol Pain; 2014 Dec; 10():77. PubMed ID: 25481027
[TBL] [Abstract][Full Text] [Related]
5. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
[TBL] [Abstract][Full Text] [Related]
6. Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain.
M'Dahoma S; Gadotti VM; Zhang FX; Park B; Nam JH; Onnis V; Balboni G; Lee JY; Zamponi GW
Pflugers Arch; 2016 Feb; 468(2):193-9. PubMed ID: 26354962
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
[TBL] [Abstract][Full Text] [Related]
8. Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels.
Gadotti VM; Antunes FTT; Zamponi GW
Mol Brain; 2023 May; 16(1):47. PubMed ID: 37231418
[TBL] [Abstract][Full Text] [Related]
9. A Synthetically Accessible Small-Molecule Inhibitor of USP5-Cav3.2 Calcium Channel Interactions with Analgesic Properties.
Garcia-Caballero A; Gadotti VM; Ali MY; Bladen C; Gambeta E; Van Humbeck JF; MacCallum JL; Zamponi GW
ACS Chem Neurosci; 2022 Feb; 13(4):524-536. PubMed ID: 35113527
[TBL] [Abstract][Full Text] [Related]
10. The terpenes camphene and alpha-bisabolol inhibit inflammatory and neuropathic pain via Cav3.2 T-type calcium channels.
Gadotti VM; Huang S; Zamponi GW
Mol Brain; 2021 Nov; 14(1):166. PubMed ID: 34775970
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.
Gadotti VM; Bladen C; Zhang FX; Chen L; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2015 Dec; 467(12):2485-93. PubMed ID: 26286466
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of interleukin-6 on Ca
Liu Q; Chen W; Fan X; Wang J; Fu S; Cui S; Liao F; Cai J; Wang X; Huang Y; Su L; Zhong L; Yi M; Liu F; Wan Y
Exp Neurol; 2019 Jul; 317():226-243. PubMed ID: 30872136
[TBL] [Abstract][Full Text] [Related]
13. Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis.
Shin SM; Cai Y; Itson-Zoske B; Qiu C; Hao X; Xiang H; Hogan QH; Yu H
Mol Pain; 2020; 16():1744806920963807. PubMed ID: 33054557
[TBL] [Abstract][Full Text] [Related]
14. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
[TBL] [Abstract][Full Text] [Related]
15. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.
Bladen C; McDaniel SW; Gadotti VM; Petrov RR; Berger ND; Diaz P; Zamponi GW
ACS Chem Neurosci; 2015 Feb; 6(2):277-87. PubMed ID: 25314588
[TBL] [Abstract][Full Text] [Related]
17. The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity.
Harding EK; Dedek A; Bonin RP; Salter MW; Snutch TP; Hildebrand ME
Br J Pharmacol; 2021 Sep; 178(17):3517-3532. PubMed ID: 33871884
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Ca
Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
[TBL] [Abstract][Full Text] [Related]
19. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
Barbara G; Alloui A; Nargeot J; Lory P; Eschalier A; Bourinet E; Chemin J
J Neurosci; 2009 Oct; 29(42):13106-14. PubMed ID: 19846698
[TBL] [Abstract][Full Text] [Related]
20. Icariside II, a Prenyl-Flavonol, Alleviates Inflammatory and Neuropathic Pain by Inhibiting T-Type Calcium Channels and USP5-Cav3.2 Interactions.
Ali MY; Gadotti VM; Huang S; Garcia-Caballero A; Antunes FTT; Jung HA; Choi JS; Zamponi GW
ACS Chem Neurosci; 2023 May; 14(10):1859-1869. PubMed ID: 37116219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
